Advertisement
Screener

Rapid Therapeutic Science Laboratories, Inc. Debt Conversion, Original Debt, Amount

Rapid Therapeutic Science Laboratories, Inc. Debt Conversion, Original Debt, Amount

Rapid Therapeutic Science Laboratories, Inc. reported Debt Conversion, Original Debt, Amount of $0 for the 9-month period ending 2022-09-30, per its 10-Q filed 2022-11-10.

Discontinued › Cash Flow › Financing Activities

us-gaap:DebtConversionOriginalDebtAmount1 · last filed 2022-11-10

  • Rapid Therapeutic Science Laboratories, Inc. debt conversion, original debt, amount for the quarter ending 2022-09-30 was $0.00.
  • Rapid Therapeutic Science Laboratories, Inc. debt conversion, original debt, amount for the quarter ending 2022-06-30 was $0.00.
  • Rapid Therapeutic Science Laboratories, Inc. debt conversion, original debt, amount for the quarter ending 2022-03-31 was $0.00, a 100.00% decline year-over-year.
  • Rapid Therapeutic Science Laboratories, Inc. debt conversion, original debt, amount for the quarter ending 2021-12-31 was $0.00, a 100.00% decline year-over-year.
  • Rapid Therapeutic Science Laboratories, Inc. debt conversion, original debt, amount for fiscal 2021 was $892.32K, a 66.77% increase from fiscal 2020.
  • Rapid Therapeutic Science Laboratories, Inc. debt conversion, original debt, amount for fiscal 2020 was $535.07K.
Period endDebt Conversion, Original Debt, Amount 3 monthDebt Conversion, Original Debt, Amount 6 monthDebt Conversion, Original Debt, Amount 9 monthDebt Conversion, Original Debt, Amount 12 month
2022-09-30$0.00
derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-10
$0.00
derived: sum of 2 quarters · filed 2022-11-10
$0.00
10-Q · filed 2022-11-10
$0.00
derived: sum of 4 quarters · filed 2022-11-10
2022-06-30$0.00
derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-12
$0.00
10-Q · filed 2022-08-12
$0.00
derived: sum of 3 quarters · filed 2022-08-12
$0.00
derived: sum of 4 quarters · filed 2022-11-10
2022-03-31$0.00
10-Q · filed 2022-05-11
$0.00
derived: sum of 2 quarters · filed 2022-05-11
$0.00
derived: sum of 3 quarters · filed 2022-11-10
$0.00
derived: sum of 4 quarters · filed 2022-11-10
2021-12-31$0.00
derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-16
$0.00
derived: sum of 2 quarters · filed 2022-11-10
$0.00
derived: sum of 3 quarters · filed 2022-11-10
$892.32K
10-K · filed 2022-03-16
2021-09-30$0.00
derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-10
$0.00
derived: sum of 2 quarters · filed 2022-11-10
$892.32K
10-Q · filed 2022-11-10
$926.26K
derived: sum of 4 quarters · filed 2022-11-10
2021-06-30$0.00
derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-12
$892.32K
10-Q · filed 2022-08-12
$926.26K
derived: sum of 3 quarters · filed 2022-08-12
$1.43M
derived: sum of 4 quarters · filed 2022-08-12
2021-03-31$892.32K
10-Q · filed 2022-05-11
$926.26K
derived: sum of 2 quarters · filed 2022-05-11
$1.43M
derived: sum of 3 quarters · filed 2022-05-11
$1.43M
derived: sum of 4 quarters · filed 2022-05-11
2020-12-31$33.94K
derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-16
$535.07K
derived: sum of 2 quarters · filed 2022-03-16
$535.07K
derived: sum of 3 quarters · filed 2022-03-16
$535.07K
10-K · filed 2022-03-16
2020-09-30$501.14K
derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-10
$501.14K
derived: sum of 2 quarters · filed 2021-11-10
$501.14K
10-Q · filed 2021-11-10
2020-06-30$0.00
derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-11
$0.00
10-Q · filed 2021-08-11
2020-03-31$0.00
10-Q · filed 2021-05-14